How Much Vagus Nerve Stimulation Costs in the USA
What if a single, proven technology could slash your migraine or epilepsy treatment expenses by thousands over time? Vagus nerve stimulation cost USA typically ranges between $20,000 and $30,000 for the implant, but this upfront electrical pulse therapy can drastically reduce years of medication and emergency room bills by directly modulating brain activity to stop seizures or pain at their neurological source. Patients often recoup the investment through fewer doctor visits and lower prescription costs, as the device works continuously in the background to prevent debilitating episodes. You harness this benefit by having a surgeon place the stimulator under your collarbone, then adjust its settings with a simple magnet or smartphone app to match your daily symptom patterns.
Understanding the Financial Landscape of VNS Therapy
Understanding the financial landscape of VNS therapy begins with recognizing that the upfront cost of the device and surgical implantation in the USA typically ranges from $20,000 to $30,000, but this is only one layer. The true financial picture includes ongoing expenses for battery replacements, programming adjustments, and specialist follow-ups every few years. Navigating this landscape demands verifying payer coverage before proceeding, as many insurers classify VNS differently for epilepsy versus depression, drastically altering out-of-pocket liability.
Without prior authorization and meticulous documentation of failed alternative treatments, patients face significant denial risks for what is often a non-reversible surgical investment.
Ultimately, personal financial exposure hinges on deductibles, co-insurance caps, and the specific network status of your surgical center.
Initial Device Pricing: Out-of-Pocket vs. Insurance Coverage
The initial cost of a VNS device in the USA hinges on your payment method. Paying out-of-pocket typically means a direct expense of $15,000 to $30,000 for the implantable generator alone, excluding surgical fees. Conversely, insurance coverage for VNS therapy shifts this burden to deductibles, co-insurance, and out-of-pocket maximums. The sequence for insured patients is clear: first, confirm pre-authorization from your insurer, which often requires documented treatment-resistant epilepsy or depression. Second, pay your plan’s deductible before insurance begins cost-sharing. Finally, you may owe a co-insurance percentage (e.g., 20%) only after meeting that deductible.
- Verify pre-authorization for VNS as a covered procedure.
- Meet annual deductible (typically $1,000–$5,000).
- Pay co-insurance (e.g., 20%) up to the out-of-pocket maximum.
Non-Invasive Alternatives: GammaCore, NEMOS, and Transcutaneous Options
For patients exploring non-invasive alternatives to surgical VNS, devices like GammaCore, NEMOS, and other transcutaneous options offer a different cost structure. GammaCore, a handheld unit applied to the neck, typically involves a rental or purchase fee for the device plus ongoing costs for proprietary single-use gel pads. NEMOS, which stimulates the auricular branch of the vagus nerve via an ear electrode, requires an upfront device purchase but uses reusable components, lowering long-term consumable expenses. Unlike implanted systems, these transcutaneous options avoid the significant surgical and hospital fees, making their total out-of-pocket costs lower initially. However, variable insurance coverage for these devices means patients must verify if their plan considers them durable medical equipment, as reimbursement can be inconsistent across U.S. providers.
Monthly or Per-Session Rental Fees for External Stimulators
Monthly or per-session rental fees for external stimulators add a variable layer to VNS therapy costs. For non-implanted transcutaneous units, providers typically charge a flat monthly fee between $200 and $600, covering device access and replacement electrodes. Per-session rentals, often used in clinical settings, range from $75 to $150 each, with total cost depending on weekly session frequency. Some rental agreements bundle maintenance and replacement parts, while others itemize them separately, altering the monthly outlay. Unlike purchased devices, these fees usually exclude the initial consultation and fitting, requiring careful review of the rental contract.
| Option | Typical Fee | Key Included |
|---|---|---|
| Monthly Rental | $200–$600 | Device + electrodes |
| Per-Session Rental | $75–$150 | Device use per session |
Surgical Implantation Expenses: Breaking Down Charges
The surgical implantation expenses for VNS therapy break down into several key charges. The surgeon’s fee, anesthesia costs, and operating room usage form the core of the procedure. You’ll also face separate charges for the implantable pulse generator itself, plus the lead wire threaded around the vagus nerve. Pre-operative labs, imaging, and post-surgical monitoring in recovery add further line items. Hospital or surgical center facility fees are often the largest single chunk, varying drastically by location. Understanding this breakdown is crucial, as the total can range from $15,000 to $30,000, depending on your specific insurer’s negotiated rates and facility contracts. These Vagus nerve stimulation cost USA figures rarely include the device hardware in one lump sum; each component is billed separately.
Surgeon Fees and Hospital Facility Costs
Surgeon fees for VNS implantation typically range from $5,000 to $15,000, reflecting the neurosurgeon’s expertise in electrode placement and device programming. Hospital facility costs, covering operating room use, anesthesia, and recovery, often add $20,000 to $50,000. These two charges usually comprise 60–70% of the total procedure bill, with facility costs at a major medical center trending higher due to overhead. Insurance pre-authorization is essential, as out-of-network surgeons or hospitals can double these line items.
Surgeon fees ($5K–$15K) and hospital facility costs ($20K–$50K) together form the bulk of VNS implantation expenses, varying by provider network and hospital type.
Anesthesia, Pre-Op Testing, and Post-Surgical Monitoring
Anesthesia for VNS implantation typically adds $1,500–$3,500, depending on whether a general or monitored sedation approach is used. Pre-op testing includes EKG, blood work, and a neurological evaluation, collectively costing $800–$2,000 to confirm surgical readiness. Post-surgical monitoring in the recovery unit and overnight observation adds $1,200–$2,800, covering vital sign checks and device stimulation threshold testing. These components represent a significant portion of the total procedure cost. Pre-surgical clearance fees are often billed separately from the surgeon’s fee.
Q: Does insurance cover pre-op testing for VNS?
A: Most plans cover necessary pre-op labs and cardiac clearance, but confirm your policy’s deductible and whether anesthesia is billed under your surgical or medical benefit.
The Price Gap Between Invasive and Non-Invasive Procedures
The price gap between invasive and non-invasive VNS procedures in the USA is stark, driven by surgical overhead versus device-only costs. An implanted vagus nerve stimulator, requiring OR time, anesthesia, and surgeon fees, typically totals $20,000–$40,000. In contrast, non-invasive transcutaneous auricular VNS (taVNS) avoids surgery entirely, costing $300–$1,500 for the device and zero facility fees. This makes taVNS the most affordable entry point for vagus nerve stimulation, though it lacks the power of implanted systems for severe epilepsy. Why is non-invasive VNS cheaper than surgical implantation? Because invasive procedures include hospital stays, surgeon fees, and device sterilization, while non-invasive is simply a wearable ear clip and stimulator sold directly to patients.
Long-Term Ownership and Maintenance Costs
Beyond the initial implant, the long-term ownership and maintenance costs of Vagus nerve stimulation in the USA require careful budgeting. You will face recurring expenses for replacement batteries every 3–5 years, a surgery costing $15,000–$30,000 each time. Ongoing device interrogation appointments with your neurologist add annual fees of $500–$1,500, while programming adjustments may be billed separately. Electrode lead revisions or replacements, though rare, can cost over $10,000 if they malfunction. These cumulative costs significantly impact the total Vagus nerve stimulation cost USA, making insurance coverage for future surgeries and monitoring critical to avoid surprise out-of-pocket burdens.
Battery Replacement Surgery for Implantable Devices
Battery replacement surgery for implantable VNS devices is an inevitable, recurring cost of ownership. The generator’s lifespan typically ranges from four to eight years, after which an outpatient procedure is required to excise the depleted unit and implant a new one. This surgery incurs separate facility fees, anesthesia charges, and surgeon costs beyond the initial implant, often totaling several thousand dollars. Patients should budget for this repeating expense. Planning for VNS generator replacement surgery early prevents financial surprises, as delays due to cost can lead to a gap in therapy and symptom relapse. Generator depletion is a predictable event, not a failure.
Battery replacement surgery is a scheduled, recurring cost of VNS therapy, requiring separate procedural fees and careful financial planning to maintain uninterrupted symptom control over the device’s lifespan.
Lead Repositioning or Replacement Procedures
Lead repositioning or replacement procedures represent a distinct, often unforeseen expense within the long-term cost of vagus nerve stimulation in the USA. This surgery becomes necessary if the lead fractures, migrates, or causes a suboptimal stimulation response, typically due to scar tissue or physical trauma. The cost primarily covers the surgeon’s fee, facility charges, and the replacement hardware, with a new lead costing significantly more than repositioning the existing one. These procedures are critical because a non-functioning lead requires immediate intervention to restore therapy, adding several thousand dollars to the patient’s total ownership costs and potentially triggering a new insurance deductible cycle for the year. Post-surgical programming sessions are also required to re-optimize settings, adding further logistical and financial burden.
Annual Follow-Up Visits and Device Programming Adjustments
Annual follow-up visits are a consistent cost for VNS owners in the USA, typically occurring once per year. These appointments involve a clinician reviewing the device’s data and battery status. During the visit, device programming adjustments are made to optimize stimulation parameters, such as current output or duty cycle, which can change over time. The cost for this single visit, including the programming adjustment, generally ranges from $200 to $500 without insurance. The process typically follows this sequence:
- The clinician connects a programming wand to the patient’s implant to read current settings.
- Based on the patient’s seizure or depression response, the stimulation amplitude, frequency, or pulse width is adjusted.
- A final test ensures the new settings are tolerated, and the patient receives revised usage instructions.
Insurance Approval and Reimbursement Nuances
Securing insurance approval for Vagus nerve stimulation in the USA hinges on proving medical necessity, typically through documented failure of prior treatments like medication or therapy, which directly dictates whether the $30,000–$50,000 upfront cost becomes a manageable copay. Pre-authorization is mandatory, and denials often stem from insufficient seizure or depression logs; a robust appeal with provider support is critical. Reimbursement nuances further affect ongoing costs—battery replacement surgeries (about $15,000) may require separate approvals, and out-of-network providers can shift 30-50% of the total bill to you. Negotiate bundled pricing with your surgeon and verify coverage for programming visits to avoid surprise out-of-pocket expenses.
Medicare, Medicaid, and Private Payer Coverage Patterns
For Vagus nerve stimulation (VNS) in the USA, private payer coverage patterns typically require step-therapy failure with antidepressants or seizure medications before approval, often with high out-of-pocket costs for devices and implantation. Medicare, in contrast, covers VNS for treatment-resistant depression and epilepsy under specific diagnostic codes, but restricts coverage for off-label uses. Medicaid coverage varies sharply by state; some states deny VNS entirely unless classified as a last-resort epilepsy therapy. These diverging approval pathways mean patients must verify coverage with their specific plan before proceeding, as pre-authorization rules differ radically between public and private insurers.
Medicare covers VNS for strict indications, private payers demand step-therapy failure, and Medicaid depends on state-specific epilepsy rules.
Prior Authorization Requirements and Appeal Strategies
Navigating prior authorization for Vagus nerve stimulation often starts with confirming your specific CPT code and ICD-10 diagnosis match your insurer’s medical necessity criteria. If denied, a focused appeal requires you to submit a detailed letter of medical necessity from your neurologist, citing failed medication trials and documented seizure frequency. Always request the specific denial reason, then provide supplementary records like EEG results or a second medical opinion. Time limits for appeals vary, so submit promptly via certified mail. If the initial internal appeal fails, escalate to an external independent review, which can overturn the insurance decision without cost to you.
Out-of-Network Providers and Balanced Billing Risks
Using an out-of-network provider for vagus nerve stimulation (VNS) significantly raises your financial exposure due to balanced billing risks. When your insurer pays only a portion of the out-of-network surgeon’s or facility’s fee, the provider can legally bill you for the remaining balance—often thousands of dollars. This surprise charge is not applied to your deductible or out-of-pocket maximum. You must verify network status before surgery; scheduling with an in-network specialist removes this risk entirely.
Q: How can I avoid balanced billing for VNS surgery?
A: Confirm in writing that your surgeon, hospital, and any anesthesiologists are all in-network. Request a pre-authorization letter stating no out-of-network charges will apply.
Financial Assistance Programs for Patients
Financial assistance programs significantly offset the high upfront cost of Vagus nerve stimulation (VNS) therapy in the USA, where device implantation alone can exceed $30,000. Most major VNS manufacturers, such as LivaNova and Cyberonics, offer direct patient assistance funds that apply for implant surgery and device costs. Additionally, nonprofit foundations like the Epilepsy Foundation and the Patient Advocate Foundation provide grants specifically earmarked for VNS-related expenses, including copays for follow-up programming sessions. To access these funds, patients must typically submit a financial hardship application along with proof of insurance denial or high deductibles.
Applying before scheduling surgery is critical, as approval often takes four to six weeks and grants can deplete quarterly.
Hospitals also often have charity care policies that can reduce the remaining balance after insurance, making consistent out-of-pocket costs manageable.
Manufacturer Patient Assistance and Copay Savings Cards
Manufacturer Patient Assistance and Copay Savings Cards offset out-of-pocket VNS costs by reducing deductibles and coinsurance for eligible patients. Vagus nerve stimulation copay assistance programs typically cap annual savings, so users must verify remaining funds. Eligibility often requires commercial insurance exclusion of government plans. These cards do not lower device or surgery fees but directly apply to prescription and monitoring copays.
- Check annual benefit maximums before enrollment to avoid mid-year gaps
- Confirm the manufacturer card covers VNS generator replacement copays
- Use card at specialty pharmacies only; mail-order may reject the savings code
Nonprofit Grants for Epilepsy, Depression, or Chronic Pain
For patients facing Vagus nerve stimulation costs in the U.S., nonprofit grants for epilepsy, depression, or chronic pain can offset device and implantation expenses. Organizations like the Epilepsy Foundation and the American Pain Foundation offer direct financial aid, though eligibility typically requires documented medical necessity and income verification. Grant amounts vary widely, often covering only a fraction of the total cost, and application cycles may be annual or quarterly. These grants rarely fund ongoing maintenance or replacement costs, so patients should confirm specific coverage scopes before applying.
Negotiating Hospital Bills and Setting Up Payment Plans
When facing the high cost of Vagus nerve stimulation, directly negotiating hospital bills and setting up payment plans is a critical step. Before agreeing to any procedure, request an itemized bill to identify errors or negotiate discounts for upfront cash payments. Contact the hospital’s billing department to discuss an interest-free monthly payment plan tailored to your budget. Many facilities will reduce the total balance if you can commit to a structured, ongoing payment schedule. Always get any negotiated terms in writing before making a payment.
Request an itemized bill, negotiate a discount, and secure a written interest-free payment plan before paying anything.
Comparing Total Cost Across Common Indications
In my journey through USA treatment options, I found the total cost for vagus nerve stimulation varied sharply depending on the indication. For epilepsy, the initial surgery and device averaged $30,000–$50,000, but long-term battery replacements and programming visits often pushed five-year totals toward $80,000. Contrast that with treatment-resistant depression, where insurers typically covered outpatient implantation only after failed therapies, yet patients faced $10,000–$20,000 in out-of-pocket costs for programming sessions alone. Comparing total cost across common indications revealed a stark reality: epilepsy patients encountered higher upfront surgical fees but fewer ongoing copays, while depression patients saw lower initial bills but relentless, high-frequency follow-up charges. Beyond the implant itself, the real financial trap was cumulative titration visits—epilepsy needed fewer adjustments; depression demanded months of weekly reprogramming.
Epilepsy: FDA-Approved vs. Off-Label Pricing Differences
For epilepsy, FDA-approved VNS therapy typically results in higher upfront device costs due to rigorous clinical trial validation, whereas off-label use for conditions like treatment-resistant depression often sees lower device pricing because manufacturers set prices without the same regulatory overhead. This pricing disparity in VNS therapy means epilepsy patients may face a device cost of $20,000–$30,000, while off-label indications can reduce that by 15–30% due to lacking FDA-mandated efficacy data. However, insurance coverage is more reliable for epilepsy, often offsetting the higher sticker price.
Q: Why does FDA-approved VNS for epilepsy cost more than off-label uses?
A: The FDA approval process for epilepsy requires costly long-term safety and efficacy studies, which manufacturers embed into the device price, unlike off-label applications where no such expense is passed to the consumer.
Treatment-Resistant Depression: Added Therapy vs. Standalone Costs
For treatment-resistant depression (TRD), the cost equation splits sharply between added therapy and standalone VNS use. As added therapy for TRD, Vagus nerve stimulation inflates baseline expenses—patients still pay for ongoing medication regimens and psychotherapy sessions, creating a cumulative financial load that can exceed $50,000 in the first year. In contrast, standalone VNS eliminates those recurring therapy costs but requires the full upfront outlay of the device and implantation, typically $20,000–$35,000. The trade-off pits long-term monthly savings against a steep initial investment, making standalone cheaper over five years if you cease all other treatments.
| Aspect | Added Therapy Approach | Standalone Approach |
|---|---|---|
| Initial Device Cost | $20,000–$35,000 | $20,000–$35,000 |
| Ongoing Monthly Cost | $500–$1,200 (meds + therapy) | $0 (no added treatments) |
| 5-Year Total Estimate | $50,000–$85,000 | $20,000–$35,000 |
Rheumatoid Arthritis or Inflammatory Bowel Disease Research
Research into Rheumatoid Arthritis or Inflammatory Bowel Disease for vagus nerve stimulation focuses on reducing costly biologic drug dependency. Early trials for RA show that daily auricular stimulation can lower disease activity scores, potentially cutting annual medication expenses by thousands. For Crohn’s disease, pilot studies track how bioelectronic modulation of the vagus nerve might decrease flare frequency, thereby reducing ER visits and hospitalization costs. These investigations directly compare long-term implant or device rental fees against the lifetime price of chronic immunosuppressants, aiming to demonstrate a lower total economic burden for refractory patients.
Geographic Price Variations Within the United States
The cost of vagus nerve stimulation in the U.S. varies significantly by location. In high-cost urban centers like New York or San Francisco, the initial surgical implant can exceed $30,000, whereas in smaller Midwestern cities like Kansas City or Cleveland, the same procedure often falls between $20,000 and $25,000. Even follow-up programming sessions range from $150 in rural clinics to $400 in Boston or Los Angeles.
If you live near a major coastal city, expect to pay 25–50% more for the device and surgical fees than you would in the central U.S., even with the same insurance plan.
This price gap primarily reflects regional differences in hospital overhead and surgeon fees, not the device itself.
High-Cost Regions: Northeast and West Coast Facility Fees
Facility fees for vagus nerve stimulation implant surgery are markedly higher in the Northeast and West Coast, often adding $15,000–$30,000 to the total procedure cost compared to national averages. In cities like Boston, New York, and San Francisco, hospital outpatient department charges are typically double those of freestanding surgery centers due to higher operational overhead and concentration of specialized epilepsy centers. Even within these regions, facility fees can vary by 40% between a major academic hospital and a smaller private institution. Private insurance copays are also scaled to these inflated facility rates, resulting in larger patient out-of-pocket expenses. High-cost regions directly inflate overall VNS surgery expenses through elevated facility fees alone.
In short, choosing a facility in the Northeast or West Coast for VNS surgery can add tens of thousands of dollars compared to other U.S. regions, driven primarily by higher hospital facility fees rather than surgeon or device costs.
Midwest and Southern Markets: Lower Surgical Overhead
In the Midwest and Southern markets, lower surgical overhead for VNS implant directly reduces the total procedure cost. Surgeons here often operate in smaller, community-based hospitals or outpatient centers with lower facility fees and staff wages. This regional efficiency can shave thousands off your upfront implant bill compared to coastal urban centers. Key cost factors include:
- Reduced hospital charges at non-academic, mid-volume surgical centers
- Lower anesthesia and support staff costs in these regions
- Shorter average hospital stays, trimmed by local outpatient protocols
Rural vs. Urban Access: Travel, Lodging, and Telemedicine Expenses
For patients in rural areas, accessing VNS implantation often requires long-distance travel to urban surgical centers, adding hundreds of dollars in fuel or airfare. Lodging near the hospital for pre-operative appointments and post-operative monitoring compounds these costs significantly. Conversely, urban residents avoid such travel and housing expenses entirely. However, rural users may offset some costs through rural telemedicine follow-up sessions, which reduce the frequency of in-person visits for device programming. Yet this requires reliable broadband, which is not universal. The net result is that total VNS expenses for rural patients are usually higher due to travel and lodging, even with telemedicine savings.
Rural access adds substantial travel and lodging costs to VNS therapy, which urban patients avoid, though telemedicine can partially mitigate these expenses for follow-up care.
Hidden Expenses Often Overlooked by Patients
Beyond the device and implantation procedure, hidden expenses often overlooked by patients in Vagus nerve stimulation cost in the USA include ongoing programming fees charged per office visit to adjust settings, plus the cost of remote monitoring subscriptions that some clinics require. Replacement batteries, which must be surgically changed every 3–10 years, represent a major deferred cost not typically quoted upfront.
Patients frequently underestimate lost wages from multiple recovery days and the non-reimbursed cost of MRI-compatible leads if imaging is needed later.
Finally, many insurance plans apply separate, high deductibles to the device’s generator itself, a detail buried in the pre-authorization approval letter.
Lost Wages During Recovery and Follow-Up Visits
Lost wages during recovery and follow-up visits represent a significant hidden cost of VNS therapy. The initial implantation often requires one to two weeks off work, with hourly employees losing direct income. Each subsequent programming session, typically every few weeks for the first three months, can necessitate half-day or full-day absences. If your job involves manual labor or driving heavy machinery, your safe return to work may be delayed further by device activation adjustments. These wage losses are not covered by insurance and can easily total several thousand dollars, depending on your pay rate and distance from the clinic.
Cost of Supplemental Therapies or Device Adjustments
Beyond the device’s upfront price, patients often face hidden therapy adjustment fees that accumulate rapidly. Each reprogramming session with a specialist to fine-tune stimulation parameters can cost $150–$500, especially in the first year when optimization is frequent. Some patients require monthly adjustments to manage side effects or diminishing efficacy, turning a one-time procedure into a recurring expense. Additionally, if battery life shortens unexpectedly, device replacements add thousands. **Q: How often will I need paid adjustments?** A: Many patients need 4–6 visits in the first year alone, each costing $200–$400 out-of-pocket if insurance excludes tuning sessions.
Insurance Copays for Magnet Activation or Parameter Changes
Once your VNS device is implanted, each trip to the neurologist for a programming tweak often triggers a separate insurance copay for magnet activation or parameter changes. These visits are billed as office or procedure copays, ranging from $30 to $75 per session, and you will need multiple titration appointments over the first year to find your therapeutic threshold. Unlike the device cost itself, these copays accumulate unpredictably, as every adjustment—whether increasing output current the day after surgery or setting the magnet swipe strength months later—stacks another charge many patients fail to budget for.
Future Market Trends Affecting Out-of-Pocket Costs
Future market trends indicate that out-of-pocket costs for Vagus nerve stimulation (VNS) in the USA will likely decrease due to emerging, lower-cost non-invasive devices and manufacturer competition. This shift may reduce upfront payments for patients without insurance, though therapy maintenance fees could persist. Q: How will future trends affect my annual VNS out-of-pocket spending? A: As new wearable devices enter the market, your annual costs may drop by 20–40% within three to five years, but monitor your specific device’s consumable or subscription fees.
Patent Expirations and Generic Stimulator Competition
As brand-name vagus nerve stimulator patents expire, generic competitors enter the U.S. market, directly reducing device acquisition costs for patients. Multiple manufacturers can produce interchangeable stimulators, driving down list prices and lowering out-of-pocket expenses for those paying cash or meeting deductibles. Generic stimulator competition typically forces price reductions of thirty to fifty percent within the first two years of market entry. Patients may also see decreased replacement and component costs, as generic parts become widely available. This competitive dynamic makes initial implantation and long-term maintenance more affordable for uninsured or underinsured individuals.
Advancements in Wireless Charging and Longer Battery Life
Newer vagus nerve stimulation devices are adopting wireless charging technology, eliminating the need for frequent battery replacements and reducing long-term maintenance costs. Extended battery life now allows patients to go weeks between charges, cutting electricity use and preventing unexpected downtime that could disrupt therapy. These advancements make ownership more practical, as users avoid the expense and hassle of surgical battery swaps or purchasing external power packs. By streamlining how the device stays powered, wireless charging and longer-lasting batteries lower the total out-of-pocket burden for ongoing vagus nerve thync global, Inc. stimulation treatment.
Potential Impact of New FDA Clearances on Pricing Structures
New FDA clearances for specific VNS devices can directly compress pricing structures by introducing competing, approved alternatives. When a novel device gains clearance, previous monopolies on certain VNS applications dissolve, forcing manufacturers to lower list prices or bundle services to retain market share. This dynamic often reshapes insurance reimbursement rate negotiations, as payers leverage new FDA approvals to justify narrower coverage tiers or demand steep discounts. The patient impact is twofold: you may see lower upfront costs for newly cleared devices, but older, established systems might raise their out-of-pocket charges to offset lost volume. Q: Can a new FDA clearance reduce my monthly VNS costs? Yes, if it forces your current device’s manufacturer to drop prices or compels your insurance to renegotiate their contracted rate, lowering your copay.